Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Board fully replaced NBB
No director from three years ago is still active according to annual account 2025.
-
Busy address KBO
39 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
CHARLES RIVER LABORATORIES BELGIUM from Elsene, company number BE0431836773, closed financial year 2025 with a result of € 51,519 after tax. For that financial year CHARLES RIVER LABORATORIES BELGIUM recorded a gross margin of € 1.1 million and equity of € 473,677. Compared with financial year 2024, the result moved from € 63,305 to € 51,519. The company is profitable. The buffer shrank hard: equity is 74 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.
€ 473,677
▼ 74% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 51,519
▼ 19% vs 2024
Profit after tax over the fiscal year.
€ 711,469
▼ 19% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 1.4 million paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
4.3
▲ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 1 million
▲ 3% vs 2024
€ 241,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 46,292
▼ 37% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 307,918
▲ 10% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,208,993 | € 1,264,599 | € 1,100,831 | € 1,101,424 | |
| Profit after taxes | € 56,073 | € 176,005 | € 63,305 | € 51,519 | ▼ 19% |
| Equity | € 1,582,847 | € 1,758,852 | € 1,822,157 | € 473,677 | ▼ 74% |
| Total debts | € 507,321 | € 428,327 | € 352,906 | € 1,754,209 | ▲ € 1.4 million |
| Cash | € 662,594 | € 630,563 | € 882,320 | € 711,469 | ▼ 19% |
| Retained profit | € 1,202,847 | € 1,378,852 | € 1,442,157 | € 93,677 | ▼ 94% |
| Dividend | € 0 | € 0 | € 0 | € 1,400,000 | |
| Balance sheet total | € 2,090,168 | € 2,187,179 | € 2,175,064 | € 2,227,886 | ▲ 2% |
| Employees (FTE) | 5 | 4.9 | 4.2 | 4.3 | ▲ 0.1 |
Key figures of CHARLES RIVER LABORATORIES BELGIUM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to CHARLES RIVER LABORATORIES BELGIUM?
What happened at CHARLES RIVER LABORATORIES BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 51,519 (▼ 19% vs 2024). Source: NBB ↗
- Kevin FINN became a director. NBB
- Flavia PEASE stepped down as director. NBB
- Olivier RICHELLE became a director. NBB
- Flavia PEASE became a director. NBB
- New establishment in Elsene. KBO
- Start of the company according to the CBE. KBO
In short
From € 56,073 profit in 2022 to € 51,519 profit in 2025.
Paid € 178,577 in corporate taxes since 2022.
Best year ever: 2023, with € 176,005 profit.
On average € 256,100 of value added per employee in 2025.
A new publication or filing at CHARLES RIVER LABORATORIES BELGIUM? We notify you, reason included.
Follow CHARLES RIVER LABORATORIES BELGIUMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind CHARLES RIVER LABORATORIES BELGIUM are Olivier RICHELLE and Kevin FINN.
Directors
According to the 2025 annual accounts
Olivier RICHELLE
Director
since 2023
Kevin FINN
Director
since 2025
Flavia PEASE
Director
since 2022 · until 2025
Establishments
Establishment units
Physical locations of this company
Louizalaan 143 box 4
1050 Elsene
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 39 companies are registered at this address.
All companies at this address →Socobom
€ 123,176 gross margin · 2025
Comptoir Bogaerts
GEVELE
€ 3.7 million revenue · 2025
ELARMEC
€ 392,913 gross margin · 2025
AUSI A ET P
€ 6,839 gross margin · 2025
+34 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Mimecast
Hosting
CLOUDFLARENET - Cloudflare, Inc., US
DNS
Cloudflare DNS
Domain
Domain
criver.com
Registered
1995-05-08
Registrar
Network Solutions, LLC
Expires
2027-05-09
Website info
Features
Security
Network
Details
- Company number
- 0431.836.773
- VAT number
- BE 0431.836.773
- Registered office
- Louizalaan 143 bus 4, 1050 Elsene
- Names & denominations
- CHARLES RIVER LABORATORIES BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 August 1987
- Peppol
- Active · Active since 5 Dec 2025
- Contact
- criver.com [email protected]
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Administratieve en ondersteunende activiteiten ten behoeve van kantoren
Activiteiten van hoofdkantoren
Diverse administratieve activiteiten ten behoeve van kantoren